Jackson, MS - New research suggests that mycophenolate mofetil (MMF) can be used in the management of autoimmune inflammatory myopathy. The finding, published in the March 2005 issue of Rheumatology, ...

The new Scoring system for Cancer Risk in idiopathic Inflammatory Myositis (SCRIM), which incorporated age, sex, smoking status, dermatomyositis, anti‑transcriptional intermediary factor 1‑gamma (anti ...

Idiopathic inflammatory myopathies (IIM) represent a heterogeneous group of autoimmune disorders primarily characterised by progressive muscle weakness and inflammation, but with potential involvement ...

MIAMI, Feb. 03, 2026 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Clinical trials exploring intravenous immunoglobulin and Janus kinase inhibition headline a robust ...

Early-onset IBM challenges age-centric diagnostic criteria, with symptoms appearing in patients younger than 46. Younger IBM patients show a higher rate of mitochondrial DNA mutations, indicating ...

History gathering should solicit the patient’s abilities or limitations with these activities of daily living (ADLs). The patient may have mild arthralgias. Lungs are the most common extra muscular ...

Idiopathic inflammatory myopathies (IIMs) comprise a group of inflammatory disorders in which there is chronic inflammation of skeletal muscle. This is then followed by muscle weakness. One type of ...

Peter Frampton, British rock star and icon shared in 2019 that he has inclusion body myositis , a muscular inflammatory disease that can impact the strength of the legs, arms, and fingers. He ...

Initiation of the IIMPACT study follows promising Phase 1 results where Restem-L demonstrated clinically meaningful efficacy and a significant reduction in steroid use within 6 months in Idiopathic ...

The MarketWatch News Department was not involved in the creation of this content. -- Initiation of the IIMPACT study follows promising Phase 1 results where Restem-L demonstrated clinically meaningful ...